Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.

Kuvin JT, Dave DM, Sliney KA, Mooney P, Patel AR, Kimmelstiel CD, Karas RH.

Am J Cardiol. 2006 Sep 15;98(6):743-5. Epub 2006 Jul 26.

PMID:
16950175
[PubMed - indexed for MEDLINE]
2.

The antiatherogenic role of high-density lipoprotein cholesterol.

Kwiterovich PO Jr.

Am J Cardiol. 1998 Nov 5;82(9A):13Q-21Q. Review.

PMID:
9819099
[PubMed - indexed for MEDLINE]
3.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7. Review.

PMID:
18427276
[PubMed - indexed for MEDLINE]
4.

Extended-release niacin for modifying the lipoprotein profile.

Guyton JR.

Expert Opin Pharmacother. 2004 Jun;5(6):1385-98. Review.

PMID:
15163282
[PubMed - indexed for MEDLINE]
5.

Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice.

Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES.

Neth J Med. 2004 Jul-Aug;62(7):229-34. Review.

PMID:
15554597
[PubMed - indexed for MEDLINE]
Free Article
6.

The effects of niacin on lipoprotein subclass distribution.

Morgan JM, Carey CM, Lincoff A, Capuzzi DM.

Prev Cardiol. 2004 Fall;7(4):182-7; quiz 188. Review.

PMID:
15539965
[PubMed - indexed for MEDLINE]
7.

High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.

Toth PP.

Am J Cardiol. 2005 Nov 7;96(9A):50K-58K; discussion 34K-35K. Epub 2005 Sep 15. Review.

PMID:
16291015
[PubMed - indexed for MEDLINE]
8.

New perspectives on the use of niacin in the treatment of lipid disorders.

McKenney J.

Arch Intern Med. 2004 Apr 12;164(7):697-705. Review.

PMID:
15078639
[PubMed - indexed for MEDLINE]
9.

Antiatherothrombotic effects of nicotinic acid.

Rosenson RS.

Atherosclerosis. 2003 Nov;171(1):87-96. Review.

PMID:
14642410
[PubMed - indexed for MEDLINE]
10.

Safety of niacin and simvastatin combination therapy.

Bays H.

Am J Cardiol. 2008 Apr 17;101(8A):3B-8B. doi: 10.1016/j.amjcard.2008.02.026. Review.

PMID:
18375239
[PubMed - indexed for MEDLINE]
11.

The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers.

Kuvin JT, Karas RH.

Curr Opin Cardiol. 2003 Jul;18(4):295-300. Review.

PMID:
12858128
[PubMed - indexed for MEDLINE]
12.

Present-day uses of niacin: effects on lipid and non-lipid parameters.

Sanyal S, Karas RH, Kuvin JT.

Expert Opin Pharmacother. 2007 Aug;8(11):1711-7. Review.

PMID:
17685887
[PubMed - indexed for MEDLINE]
13.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Review.

PMID:
18480348
[PubMed - indexed for MEDLINE]
14.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Postgrad Med J. 2008 Nov;84(997):590-8. doi: 10.1136/hrt.2007.125401. Review.

PMID:
19103817
[PubMed - indexed for MEDLINE]
15.

Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.

Brown BG, Zhao XQ, Chait A, Frohlich J, Cheung M, Heise N, Dowdy A, DeAngelis D, Fisher LD, Albers J.

Can J Cardiol. 1998 Apr;14 Suppl A:6A-13A. Review.

PMID:
9594927
[PubMed - indexed for MEDLINE]
16.

High-density lipoprotein metabolism: potential therapeutic targets.

Davidson MH, Toth PP.

Am J Cardiol. 2007 Dec 3;100(11 A):n32-40. Review.

PMID:
18047851
[PubMed - indexed for MEDLINE]
17.

Dyslipidaemia in diabetic patients: time for a rethink.

Shepherd J.

Diabetes Obes Metab. 2007 Sep;9(5):609-16. Review.

PMID:
17697054
[PubMed - indexed for MEDLINE]
18.

The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.

Tellis CC, Tselepis AD.

Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Review.

PMID:
19272461
[PubMed - indexed for MEDLINE]
Free Article
19.

Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels.

Greenfeder S.

Curr Med Chem. 2009;16(2):144-56. Review.

PMID:
19149567
[PubMed - indexed for MEDLINE]
20.

Mechanism of action of niacin.

Kamanna VS, Kashyap ML.

Am J Cardiol. 2008 Apr 17;101(8A):20B-26B. doi: 10.1016/j.amjcard.2008.02.029. Review.

PMID:
18375237
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk